Fundamental Analysis of POXEL SA(EPA:POXEL) stock

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to POXEL. POXEL was compared to 80 industry peers in the Biotechnology industry. Both the profitability and financial health of POXEL have multiple concerns. POXEL is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year POXEL has reported negative net income.

POXEL had a negative operating cash flow in the past year.

In the past 5 years POXEL reported 4 times negative net income.

POXEL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -345.44%, POXEL is doing worse than 90.67% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROIC	N/A

ROA(3y)-60.88%

ROA(5y)-43.4%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 0.13%, POXEL is in line with its industry, outperforming 41.33% of the companies in the same industry.

POXEL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	0.13%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for POXEL has been increased compared to 1 year ago.

Compared to 5 years ago, POXEL has more shares outstanding

The debt/assets ratio for POXEL is higher compared to a year ago.

2.2 Solvency

POXEL has an Altman-Z score of -13.43. This is a bad value and indicates that POXEL is not financially healthy and even has some risk of bankruptcy.

POXEL's Altman-Z score of -13.43 is on the low side compared to the rest of the industry. POXEL is outperformed by 85.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-13.43

ROIC/WACCN/A

WACC7.45%

2.3 Liquidity

POXEL has a Current Ratio of 0.77. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.77, POXEL is doing worse than 85.33% of the companies in the same industry.

POXEL has a Quick Ratio of 0.77. This is a bad value and indicates that POXEL is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of POXEL (0.77) is worse than 84.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.77
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

POXEL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.62%.

Looking at the last year, POXEL shows a very strong growth in Revenue. The Revenue has grown by 650.49%.

The Revenue for POXEL have been decreasing by -33.77% on average. This is quite bad

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-78.52%

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y-33.77%

Sales Q2Q%509.64%

3.2 Future

The Earnings Per Share is expected to decrease by -8.92% on average over the next years.

Based on estimates for the next years, POXEL will show a very strong growth in Revenue. The Revenue will grow by 86.16% on average per year.

EPS Next Y39.72%

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

EPS Next 5Y-8.92%

Revenue Next Year-49.6%

Revenue Next 2Y322.98%

Revenue Next 3Y54.02%

Revenue Next 5Y86.16%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

POXEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year POXEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.27%

EPS Next 3Y-1.77%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for POXEL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

POXEL SA

EPA:POXEL (7/26/2024, 7:00:00 PM)

0.575

+0.07 (+15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap28.31M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-345.44%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	0.13%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.77
Quick Ratio	0.77
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-42.62%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y39.72%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)650.49%

Revenue growth 3Y-70.61%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

POXEL SA (POXEL.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens